UK Patients of Bangladeshi Descent with Crohn's Disease Respond Less Well to TNF Antagonists Than Caucasian Patients.

Radha GadhokHannah GordonGregory Sebepos-RogersSamantha BaillieSaniath AkbarJane E AbbottEmma MichaelOmer F AhmadBen CooperJames O Lindsay

Published in: Digestive diseases and sciences (2019)

This is the first study to suggest that Bangladeshi patients resident in the UK with CD respond less well to treatment with TNF antagonists than Caucasian patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
smoking cessation
combination therapy